Benzodiazepine prescribing practices for homeless veterans with mental illness

Despite elevated risk for substance use disorder and overdose death in the homeless population, benzodiazepine prescribing for this population has not been examined.

Menarini signs agreement for Astellas’ rheumatoid arthritis therapy

Smyraf is intended for the treatment of rheumatoid arthritis. Credit: BlurryMe/Shutterstock.com. Menarini Asia-Pacific has entered a long-term exclusive agreement to license Astellas Pharma’s Smyraf to

September 13, 2023

Genetic marker could revolutionize neonatal sepsis diagnosis

A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study.

October 29, 2024

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.